Maintaining Viral Suppression in HIV: Insights on Switching Treatments and Emerging Agents
Sharon Walmsley, CM, MD, FRCPC discusses the importance of maintaining viral suppression in HIV through strategic treatment switches and highlights insights on promising emerging therapeutic agents.
Episodes
April 30th 2025EP. 1: HIV Viral Suppression: Clinical Significance and Impact on Patient Outcomes
A panelist discusses how viral suppression in HIV patients means achieving undetectable virus levels (below 50 or 20 copies per ml), which prevents immune system damage and transmission to others, summarized as "undetectable equals untransmissible" (U=U).
April 30th 2025EP. 2: Changing Patient Demographics in HIV and Impacts of Polypharmacy on Treatment
A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now exceeding 50 years and expected to soon exceed 65 years, and how these aging patients experience more comorbidities at younger ages than the general population while their HIV becomes easier to manage with simple regimens.
